合成粘液バイオマテリアルは,炎症性腸疾患における局所的な治療用抗体投与を可能にします
Taj Yeruva1, Sydney Yang1, Michele Kaluzienski1
1Fischell Department of Bioengineering, University of Maryland, College Park, MD 20742, USA.
bioRxiv : the preprint server for biology
|September 2, 2025
まとめ
この研究は,炎症性腸疾患 (IBD) の治療において,TNFα抗体の標的型投与のための新しいムシン基ヒドロゲルを導入する. この局所的なアプローチは,全身の副作用を最小限に抑えながら,抗体の吸収と治療効果を高めます.
科学分野:
- バイオマテリアル科学
- 胃腸内科
- 免疫学
背景:
- 炎症性腸疾患 (IBD) は,しばしば抗TNF-α単体抗体 (mAbs) による慢性的な治療を必要とします.
- これらのmAbsの全身投与は 免疫抑制やターゲット設定の悪さなどの副作用を引き起こします
- IBDの治療効果と安全性を高めるには局所薬剤投与システムが必要です.
研究 の 目的:
- IBDにおけるTNF-α標的 mAbsの局所的投与のための合成ムシン基ヒドロゲルの開発と評価.
- これらのヒドロゲルの生物互換性,薬物の放出運動,および治療の可能性を評価する.
- 系統的に投与されたmAbsと比較して,ヒドロゲルで投与されたmAbsのin vivo性能を比較する.
主な方法:
- 合成ムシン基のヒドロゲルは,豚のムシンと4アームのPEG- thiolをクロスリンクすることで作られました.
- 抗TNF-αmAbsを搭載した水素ゲルは,シミュレートされた胃腸状態で細胞適合性と抗体放出をテストした.
- 液体ゲルとmAbのバイオアクティビティを評価するために,LPSで刺激されたマクロファージを対象としたインビトロ研究が行われました.
- TNBS誘発性大腸炎のマウスを用いて実施されたインビオ試験では,水溶液投与による生物分布と治療効果を評価した.
主要な成果:
- ミューシン基の水素ゲルは細胞適合性があり,タンパク質分解環境で加速放出した全長IgG抗体を持続的に放出しました.
- ハイドロゲルは単独でマクロファージの活性化を調節し,mAb負荷のハイドロゲルは抗体バイオアクティビティを保持し,炎症誘発性サイトカインの産生を減少させた.
- 溶液投与と比較して,ヒドロゲルで投与されたmAbsの吸収と粘着が強化された.
- 水素ゲルによる局所投与により,治療効果が向上し,全身曝露が減少しました.
結論:
- 合成ムチン基のヒドロゲルはIBDの局所的な投与のための有望なプラットフォームです.
- このアプローチは,TNF-αの治療標的化を改善し,薬物吸収を高め,全身免疫抑制を最小限に抑えることができます.
- mAbの投与と有効性を最適化することで,IBDの管理を改善するための潜在的な戦略を提供します.
関連する概念動画
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
230
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
230
01:29Inflammatory Bowel Disease IV: Pharmacological Management
185
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
185
01:29Drugs for Treatment of Ulcerative Colitis in IBD
236
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
236
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
201
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
201
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
264
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
264
01:21Inflammatory Bowel Disease V: Surgical Management
206
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
206